Bio/Pharma Business

From politics to paychecks and downsizings to deadlines-what it's like to work for one of the world's largest industries.

Pfizer to Shut Parsippany Plant

Contract services providers gained a valuable look into major market conditions, offshoring trends, and 2006 growth opportunities during a morning presentation entitled "CMC Sourcing in transition: Consolidation, Offshoring, and the Market Outlook," presented by Jim Miller. Miller is president of PharmSource (Springfield, VA, www.pharmsource.com), publisher of the Bio/Pharmaceutical Outsourcing , and contributing editor of Pharmaceutical Technology.

Roche Puts Hold on Tamiflu in US

Novartis Purchases Chiron in a Total Buyout

Biogen to Cut Jobs

MGI Pharma To Buy Guilford

Teva Absorbs Ivax In $7.4 Billion Bid

Aptuit To Purchase Quintiles

Able Labs Files for Chapter 11

Xanodyne Acquires aaiPharma Assets

Able Interim Chief Resigns Amid Drug Recall

Singapore is competing aggressively with India and China for a piece of the Asian sourcing business.

Schering AG To Cut Plants and Staff

Wyeth and Purdue Announce Restructuring Plans

Eli Lilly Scales Back Planned Virginia Insulin Plant

A myopic focus on short-term growth can endanger the community. The question is, can we enlighten our self-interest before the edifice falls down around our ears?

The Chapter 11 bankruptcy filing of aaiPharma (Wilmington, NC, www.aaipharma.com), parent of AAI Development Services, was the culmination of an agonizing year-long odyssey. It also was a first step in restoring one of the best-known brands in the CRO industry.

New Graduate Program Focuses On Pharmaceutical Technology

Pharmaceutical Technology has joined with INTERPHEX to found GenerationNext, an award program to recognize emerging leaders in pharmaceutical science and technology.

Crucell and NIH Sign Ebola Vaccine Manufacturing Contract

Pfizer Announces $4B/Year Cutbacks

Managers of FDA-regulated firms must be proactive in how they manage their company?s compliance with good manufacturing practices regulations.

Achieving the promised benefits of offshore sourcing to India and China is more complicated than it seems.

Innovators and generics makers are staking out positions on follow-on proteins and other manufacturing issues.

Managers of FDA-regulated firms must be proactive in how they manage their company's compliance with good manufacturing practices regulations.

Shortages of Key Drugs

After a five-year downturn, cautious optimism is taking hold among API manufacturers.

This article outlines a comprehensive approach for organizing a firm's aseptic operations, including planning for routine and nonroutine interventions, establishing effective process simulations, and determining which vials to incubate.